Literature DB >> 20189594

Sevoflurane postconditioning attenuates spinal cord reperfusion injury through free radicals-mediated up-regulation of antioxidant enzymes in rabbits.

Qiang Wang1, Qiong Chen, Qian Ding, Qianzi Yang, Ye Peng, Yan Lu, Jiao Deng, Lize Xiong.   

Abstract

BACKGROUND: Paraplegia is one of the most common complications following aortic aneurismal surgery. The present study examined the hypothesis that neuroprotection of sevoflurane postconditioning (PostC) against spinal cord reperfusion injury is associated with free radicals-mediated up-regulation of antioxidant enzymes in rabbits.
MATERIALS AND METHODS: New Zealand White rabbits were subjected to sevoflurane PostC, oxygen (O(2)), or sham treatment at the onset of spinal cord reperfusion for 10 min. Spinal cord ischemia was induced by clamping the aorta both below the left renal artery and above the aortic bifurcation. Forty-eight hours after reperfusion, the motor function of the lower limbs was evaluated and the lumbar spinal cord segment (L5-7) was harvested for histopathologic and biochemical analyses in the presence or absence of N-2-mercaptopropionylglycine, a potent oxygen free radical scavenger.
RESULTS: Activities of superoxide dismutase and catalase in spinal cord tissue were increased in the sevoflurane PostC group 1 h after reperfusion and retained a higher level 6 or 24 h after reperfusion. Sevoflurane PostC produced a significant reduction of the malondialdehyde content at 6, 24, and 48 h after reperfusion. A 20 min continuous administration of N-2-mercaptopropionylglycine starting 10 min before the beginning of PostC attenuated the neuroprotective effect against spinal cord ischemia, and reversed the increase of the two enzyme activities in spinal cord tissue induced by sevoflurane PostC.
CONCLUSION: An initial oxidative stress, as a trigger to up-regulate the antioxidant enzyme activities, plays an important role in the protection of sevoflurane PostC against spinal cord reperfusion injury.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20189594     DOI: 10.1016/j.jss.2009.11.707

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Volatile anesthetic post-treatment induces protection via inhibition of glycogen synthase kinase 3β in human neuron-like cells.

Authors:  D Lin; G Li; Z Zuo
Journal:  Neuroscience       Date:  2011-01-28       Impact factor: 3.590

Review 2.  Biological networks in ischemic tolerance - rethinking the approach to clinical conditioning.

Authors:  Josef Anrather; John M Hallenbeck
Journal:  Transl Stroke Res       Date:  2013-02       Impact factor: 6.829

3.  Neuroprotective effects of sevoflurane against electromagnetic pulse-induced brain injury through inhibition of neuronal oxidative stress and apoptosis.

Authors:  Bin Deng; Hao Xu; Jin Zhang; Jin Wang; Li-Chun Han; Li-Ya Li; Guang-Li Wu; Yan-Ning Hou; Guo-Zhen Guo; Qiang Wang; Han-Fei Sang; Li-Xian Xu
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

Review 4.  Ischemic Tolerance of the Brain and Spinal Cord: A Review.

Authors:  Masatoshi Yunoki; Takahiro Kanda; Kenta Suzuki; Atsuhito Uneda; Koji Hirashita; Kimihiro Yoshino
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-09-27       Impact factor: 1.742

Review 5.  The effect of pre- and after-treatment of sevoflurane on central ischemia tolerance and the underlying mechanisms.

Authors:  Hao Xu; Xiao-Peng Mei; Li-Xian Xu
Journal:  J Dent Anesth Pain Med       Date:  2018-02-27

6.  Sevoflurane pretreatment regulates abnormal expression of MicroRNAs associated with spinal cord ischemia/reperfusion injury in rats.

Authors:  Dan Wang; Bo Fang; Zhilin Wang; Xiaoqian Li; Fengshou Chen
Journal:  Ann Transl Med       Date:  2021-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.